Zobrazeno 1 - 10
of 23
pro vyhledávání: '"CBiPES"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mark J. Benvenga, Stephen F. Chaney, Melvyn Baez, Thomas C. Britton, William J. Hornback, James A. Monn, Gerard J. Marek
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
There is substantial evidence that glutamate can modulate the effects of 5-hydroxytryptamine2A (5-HT2A) receptor activation through stimulation of metabotropic glutamate2/3 (mGlu2/3) receptors in the prefrontal cortex. Here we show that constitutive
Externí odkaz:
https://doaj.org/article/9f965940a60d4dd5ac6205b068ebae96
Autor:
Adjia Hamadjida, Imane Frouni, Sébastien Belliveau, Woojin Kang, Dominique Bédard, Jim C. Gourdon, Stephen G. Nuara, Cynthia Kwan, Philippe Huot
Publikováno v:
Journal of Neural Transmission. 128:73-81
Advanced Parkinson’s disease (PD) is often complicated by the occurrence of dyskinesia, motor fluctuations and psychosis. To this day, few treatment options are available for each of these phenomena, and they are at times not effective or elicit ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ce71a226053805a7d777dc6b0d9db1b
https://doi.org/10.1007/s00702-020-02287-8
https://doi.org/10.1007/s00702-020-02287-8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ulrike Dijkman, Joost H.A. Folgering, Gunnar Flik, Ben H.C. Westerink, Kenneth W. Perry, Kjell A. Svensson, Matthew J. Fell, Bryan J. Johnson
Publikováno v:
Neuropharmacology. 99:1-8
The interactions between the glutamatergic and the histaminergic systems in the brain are not fully understood. Here we studied histamine release in the medial prefrontal cortex and the posterior hypothalamus-tuberomamillary nucleus (PH-TMN) using in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7d7ab7db66affa816a3019d3f0aa2dc
https://doi.org/10.1016/j.neuropharm.2015.05.034
https://doi.org/10.1016/j.neuropharm.2015.05.034
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mark J, Benvenga, Stephen F, Chaney, Melvyn, Baez, Thomas C, Britton, William J, Hornback, James A, Monn, Gerard J, Marek
Publikováno v:
Frontiers in Pharmacology
There is substantial evidence that glutamate can modulate the effects of 5-hydroxytryptamine2A (5-HT2A) receptor activation through stimulation of metabotropic glutamate2/3 (mGlu2/3) receptors in the prefrontal cortex. Here we show that constitutive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6c0af9b23c7f0343c501750daec48ed5
https://pubmed.ncbi.nlm.nih.gov/29599719
https://pubmed.ncbi.nlm.nih.gov/29599719
Publikováno v:
Epilepsy Research. 108:171-181
Novel treatments for epilepsy are necessary because many epilepsy patients are resistant to medication. Metabotropic glutamate receptors (mGluRs), specifically mGluR 2 and 3, may serve as antiepileptic drug targets because of their role in controllin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ab8698031e11a48023d591badb50f33
https://doi.org/10.1016/j.eplepsyres.2013.10.009
https://doi.org/10.1016/j.eplepsyres.2013.10.009
Autor:
Ellen M. Colvin, Emanuele Sher, Olivera Grubisha, Richard G. Vivier, James A. Monn, Lydia Hanna, Jeremy Findlay, Beverly A. Heinz, Lisa M. Broad, David Lodge, Daniel Ursu, Helen E. Sanger
Publikováno v:
Neuropharmacology. 66:264-273
The group II metabotropic glutamate (mGlu) receptors comprised of the mGlu2 and mGlu3 receptor subtypes have gained recognition in recent years as potential targets for psychiatric disorders, including anxiety and schizophrenia. In addition to studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ec5be3a3cdca1fba4e9c5e68a225f7b
https://doi.org/10.1016/j.neuropharm.2012.05.023
https://doi.org/10.1016/j.neuropharm.2012.05.023
Autor:
Philip L. Johnson, Anantha Shekhar, Eric A. Engleman, Jeffrey M. Schkeryantz, Stephanie D. Fitz, Kjell Svensson
Publikováno v:
Journal of Psychopharmacology. 27:152-161
Rats with chronic inhibition of GABA synthesis by infusion of l-allyglycine, a glutamic acid decarboxylase inhibitor, into their dorsomedial/perifornical hypothalamus are anxious and exhibit panic-like cardio-respiratory responses to treatment with i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a14eb4d48434135dd1aab9597345a13a
https://doi.org/10.1177/0269881112454230
https://doi.org/10.1177/0269881112454230